• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[成年患者佩罗尼氏病的病理生理学与管理:最新进展]

[Pathophysiology and management of Peyronie's disease in adult patients: an update].

作者信息

Alenda O, Beley S, Ferhi K, Cour F, Chartier-Kastler E, Haertig A, Richard F, Rouprêt M

机构信息

Services d'urologie de la Pitié-Salpêtrière et de l'hôpital Tenon, Assistance publique-Hôpitaux de Paris, groupe hospitalo-universitaire Est, faculté de médecine Pierre-et-Marie-Curie, université Paris-VI, Paris, France.

出版信息

Prog Urol. 2010 Feb;20(2):91-100. doi: 10.1016/j.purol.2009.05.010. Epub 2009 Jul 3.

DOI:10.1016/j.purol.2009.05.010
PMID:20142049
Abstract

Peyronie's disease (PD) is due to a fibrotic plaque forms in the tunica albuginea layer of the penis. It is responsible of penile pain, angulation, and erectile dysfunction. Even though the aetiology remains unknown, the knowledge of the pathophysiology has evolved in recent years. Recent studies indicate that PD has prevalence of 3 to 9% in adult men. During the initial acute phase (6 to 18 months), the condition may progress, stabilize or regress in 20%. Therefore, a conservative treatment approach has been advocated. An initial discussion about evaluation, information, and reassurance is necessary in most cases. The most commonly employed oral therapies include tocopherol (vitamin E), and para-aminobenzoate (Potaba), which have failed to demonstrate efficiency. Intralesional injection therapies with interferon alpha-2B, verapamil are frequently used as a first-line treatment modality, and can provide an improvement in decreasing penile pain and penile curvature. Current literature has shown that extracorporeal shock wave lithotripsy was only active on the pain. Regarding penile curvature, there are discrepancies in the published series. The surgical approach is restricted to men unresponsive to nonoperative therapies (i.e., 10% of patients). In such cases, plication, grafting or even penile prosthesis implantation are conceivable management options.

摘要

佩罗尼氏病(PD)是由于阴茎白膜层形成纤维化斑块所致。它会导致阴茎疼痛、弯曲和勃起功能障碍。尽管病因尚不清楚,但近年来对其病理生理学的认识有所发展。最近的研究表明,PD在成年男性中的患病率为3%至9%。在最初的急性期(6至18个月),病情可能进展、稳定或20%的患者病情会缓解。因此,一直提倡采用保守治疗方法。在大多数情况下,有必要就评估、信息告知和安抚患者进行初步讨论。最常用的口服疗法包括生育酚(维生素E)和对氨基苯甲酸(Potaba),但这些疗法尚未证明有效。干扰素α-2B、维拉帕米的病灶内注射疗法经常被用作一线治疗方式,并且在减轻阴茎疼痛和阴茎弯曲方面可以带来改善。目前的文献表明,体外冲击波碎石术仅对疼痛有效。关于阴茎弯曲,已发表的系列研究结果存在差异。手术方法仅限于对非手术疗法无反应的男性(即10%的患者)。在这种情况下,折叠术、移植术甚至阴茎假体植入术都是可行的治疗选择。

相似文献

1
[Pathophysiology and management of Peyronie's disease in adult patients: an update].[成年患者佩罗尼氏病的病理生理学与管理:最新进展]
Prog Urol. 2010 Feb;20(2):91-100. doi: 10.1016/j.purol.2009.05.010. Epub 2009 Jul 3.
2
Medical management of Peyronie's disease.佩罗尼氏病的医学管理。
J Androl. 2009 Jul-Aug;30(4):397-405. doi: 10.2164/jandrol.108.006221. Epub 2008 Oct 30.
3
Pharmacological Management of Peyronie's Disease.佩罗尼氏病的药物治疗
Drugs. 2007;67(4):527-45. doi: 10.2165/00003495-200767040-00004.
4
Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options.当前 Peyronie 病的现状和新进展:医学、微创和手术治疗选择。
Expert Opin Pharmacother. 2011 Apr;12(6):931-44. doi: 10.1517/14656566.2011.544252.
5
Review of Management Options for Patients With Atypical Peyronie's Disease.《不典型性佩罗尼病患者的治疗选择综述》。
Sex Med Rev. 2017 Apr;5(2):211-221. doi: 10.1016/j.sxmr.2016.07.004. Epub 2016 Aug 17.
6
Management of Peyronie's disease--a review.佩罗尼氏病的治疗——综述
World J Urol. 2001 Aug;19(4):244-50.
7
Peyronie's disease (CME).佩罗尼氏病(继续医学教育)
J Sex Med. 2007 Nov;4(6):1527-38. doi: 10.1111/j.1743-6109.2007.00614.x.
8
EAU guidelines on penile curvature.EAU 指南:阴茎弯曲
Eur Urol. 2012 Sep;62(3):543-52. doi: 10.1016/j.eururo.2012.05.040. Epub 2012 May 25.
9
Peironimev-Plus® in the treatment of chronic inflammation of tunica albuginea (Peyronie's disease). results of a controlled study.佩罗尼米夫-加®治疗白膜慢性炎症(佩罗尼氏病)。一项对照研究的结果。
Inflamm Allergy Drug Targets. 2013 Feb;12(1):61-7. doi: 10.2174/1871528111312010009.
10
Peyronie's disease.佩罗尼氏病
J Sex Med. 2004 Jul;1(1):110-5. doi: 10.1111/j.1743-6109.2004.10116.x.

引用本文的文献

1
The histopathological effects of intracavernosal mitomycin-C injection in a rat Peyronie's disease model.海绵体内注射丝裂霉素-C对大鼠佩罗尼氏病模型的组织病理学影响。
Can Urol Assoc J. 2017 Nov;11(11):E441-E445. doi: 10.5489/cuaj.4489.
2
Role of interleukin-6 and pentraxin 3 as an early marker in Peyronie's disease.白细胞介素-6和五聚素3作为佩罗尼氏病早期标志物的作用。
Kaohsiung J Med Sci. 2017 Apr;33(4):195-200. doi: 10.1016/j.kjms.2017.01.007. Epub 2017 Feb 28.